Provectus Biopharmaceuticals, Inc. Share Price
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
09:23:03 15/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.0500 USD | 0.00% |
|
0.00% | -10.55% |
| Market Cap | 2.1Cr 1.88Cr 1.74Cr 1.59Cr 2.98Cr 199.03Cr 3.04Cr 21Cr 8.19Cr 103.85Cr 7.89Cr 7.72Cr 332.3Cr | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 2.37Cr 2.12Cr 1.97Cr 1.79Cr 3.37Cr 224.87Cr 3.43Cr 24Cr 9.26Cr 117.32Cr 8.91Cr 8.72Cr 375.43Cr | EV / Sales 2024 |
8,64,51,912x | EV / Sales 2025 | 7,80,13,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| Current month | -12.43% | ||
| 1 month | -10.07% | ||
| 3 months | -21.51% | ||
| 6 months | -5.66% | ||
| Current year | -10.55% |
| 1 week | 0.05 |  | 0.06 |
| 1 month | 0.05 | | 0.06 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.08 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 16/04/2024 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/2012 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 25/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
John Lacey
BRD | Director/Board Member | 78 | 27/04/2018 |
| Chairman | 57 | 03/04/2017 | |
Edward Pershing
CHM | Chairman | 73 | 27/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/10/26 | Exercice | Chief Executive Officer | -22,609 | 0.0054% | ||
| 03/10/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 18/09/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -33.64% | -28.57% | 2.1Cr | |
| +0.21% | -4.63% | +55.34% | +71.32% | 6.9TCr | |
| +0.29% | +4.48% | +7.00% | +61.91% | 5.31TCr | |
| -0.28% | +5.17% | +9.78% | +41.23% | 5.08TCr | |
| +3.45% | +4.70% | +33.44% | +35.96% | 4.46TCr | |
| -2.20% | +0.61% | +281.88% | +532.76% | 4.06TCr | |
| +6.43% | +6.84% | +18.32% | +109.23% | 4.25TCr | |
| +1.28% | +1.39% | +11.69% | +45.10% | 3.09TCr | |
| -0.90% | -10.49% | +31.48% | -1.63% | 2.54TCr | |
| +1.74% | -2.02% | -13.55% | -12.92% | 2.27TCr | |
| Average | +1.00% | +1.40% | +40.17% | +85.44% | 3.8TCr | |
| Weighted average by Cap. | +1.08% | +2.33% | +50.68% | +103.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.55 0.51 0.47 0.88 58.45 0.89 6.15 2.41 30.5 2.32 2.27 97.59 | 0.34 0.3 0.28 0.25 0.48 31.83 0.49 3.35 1.31 16.61 1.26 1.23 53.15 |
| Net income | -47.62L -42.51L -39.51L -35.94L -67.61L -45Cr -68.83L -4.75Cr -1.86Cr -24Cr -1.79Cr -1.75Cr -75Cr | -54.31L -48.48L -45.05L -40.98L -77.1L -51Cr -78.49L -5.41Cr -2.12Cr -27Cr -2.04Cr -1.99Cr -86Cr |
| Net Debt | 28.77L 25.68L 23.87L 21.71L 40.85L 27Cr 41.59L 2.87Cr 1.12Cr 14Cr 1.08Cr 1.06Cr 45Cr | 27.27L 24.34L 22.63L 20.58L 38.72L 26Cr 39.42L 2.72Cr 1.06Cr 13Cr 1.02Cr 1Cr 43Cr |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | $0.0500 | 0.00% | 1,49,305 |
| 14/26/14 | $0.0500 | -9.09% | 1,14,492 |
| 13/26/13 | $0.0550 | +2.04% | 14,200 |
| 12/26/12 | $0.0539 | +1.89% | 6,697 |
| 09/26/09 | $0.0529 | +5.80% | 30,409 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
